300765 新诺威
已收盘 04-23 15:00:00
资讯
新帖
简况
石药集团:石药创新一季度归母净利约7906.13万元 同比减少38.86%
智通财经 · 08:04
石药集团:石药创新一季度归母净利约7906.13万元 同比减少38.86%
图解新诺威一季报:第一季度单季净利润同比减38.86%
证券之星 · 01:48
图解新诺威一季报:第一季度单季净利润同比减38.86%
新诺威最新公告:一季度净利润7906.13万元 同比下降38.86%
证券之星 · 04-22 21:40
新诺威最新公告:一季度净利润7906.13万元 同比下降38.86%
石药集团(01093):石药创新(300765.SZ)一季度归母净利约7906.13万元 同比减少38.86%
智通财经网 · 04-22 21:35
石药集团(01093):石药创新(300765.SZ)一季度归母净利约7906.13万元 同比减少38.86%
新诺威(300765.SZ)发布一季度业绩,净利润7906.13万元,下降38.86%
智通财经 · 04-22 21:14
新诺威(300765.SZ)发布一季度业绩,净利润7906.13万元,下降38.86%
新诺威(300765.SZ)发布2023年度业绩,净利润7.56亿元,增长4.03%,拟10股转2股派3.2元
智通财经网 · 03-14
新诺威(300765.SZ)发布2023年度业绩,净利润7.56亿元,增长4.03%,拟10股转2股派3.2元
新诺威上市五年业绩连续双增 股价大涨194%两次调高回购价
长江商报 · 02-27
新诺威上市五年业绩连续双增 股价大涨194%两次调高回购价
新诺威:调整回购公司股份价格上限至38元/股
证券时报网 · 02-25
新诺威:调整回购公司股份价格上限至38元/股
新诺威:拟收购石药集团百克(山东)生物制药股份有限公司100%股权 1月11日起停牌
证券时报网 · 01-10
新诺威:拟收购石药集团百克(山东)生物制药股份有限公司100%股权 1月11日起停牌
新诺威:公司已构建独立自主mRNA技术平台 采用自主研发模式进行产品研发工作
财华社 · 01-04
新诺威:公司已构建独立自主mRNA技术平台 采用自主研发模式进行产品研发工作
【年终盘点】2023年A股十大牛熊股出炉!
财华社 · 2023-12-29
【年终盘点】2023年A股十大牛熊股出炉!
新诺威(300765.SZ)控股股东完成增持274.26万股
智通财经网 · 2023-12-21
新诺威(300765.SZ)控股股东完成增持274.26万股
新诺威尾盘20CM跌停,成交超22亿元。
港股那点事 · 2023-12-07
新诺威尾盘20CM跌停,成交超22亿元。
新诺威涨8.17%,德邦证券一周前给出“买入”评级
证券之星 · 2023-11-06
新诺威涨8.17%,德邦证券一周前给出“买入”评级
加载更多
公司概况
公司名称:
石药创新制药股份有限公司
所属行业:
食品制造业
上市日期:
2019-03-22
主营业务:
石药创新制药股份有限公司的主营业务是大健康领域功能食品的研发、生产与销售。公司的主要产品为功能性原料及保健食品类产品。公司“果维康”商标为中国驰名商标,“果维康”牌维生素C含片先后获得中国公众营养和发展中心“营养健康倡导产品”、“中华预防医学会健康金桥重点工程项目”、等多项荣誉。公司二甲紫脲酸高选择性催化还原新工艺,可可碱生产新工艺经河北省科学技术厅的认定,达到国内领先水平,并获得了河北省科学技术成果奖。公司专利“一种咖啡因中间体N,N-1,3-二甲基-4,5-二氨基脲嗪的制备方法”荣获2018年河北省专利奖优秀奖。
发行价格:
24.47
{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"新诺威","latestPrice":36.7,"timestamp":1713855834000,"preClose":35.88,"halted":0,"volume":14093634,"delay":0,"floatShares":1039000000,"shares":1171000000,"eps":0.5575,"marketStatus":"已收盘","marketStatusCode":5,"change":0.82,"latestTime":"04-23 15:00:00","open":35.17,"high":37.39,"low":33.02,"amount":499000000,"amplitude":0.1218,"askPrice":36.7,"askSize":141,"bidPrice":36.69,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.5575,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713922200000},"adr":0,"adjPreClose":35.88,"symbolType":"stock","openAndCloseTimeList":[[1713835800000,1713843000000],[1713848400000,1713855600000]],"highLimit":39.47,"lowLimit":32.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1170742154,"pbRate":8.27,"roa":"--","roe":"1.8%","epsLYR":0.6533,"committee":0.097104,"marketValue":42966000000,"floatMarketCap":38149000000,"peRate":65.829596,"changeRate":0.0229,"turnoverRate":0.0136,"status":0},"requestUrl":"/m/hq/s/300765","defaultTab":"news","newsList":[{"id":"2429664185","title":"石药集团:石药创新一季度归母净利约7906.13万元 同比减少38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429664185","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429664185?lang=zh_cn&edition=full","pubTime":"2024-04-23 08:04","pubTimestamp":1713830650,"startTime":"0","endTime":"0","summary":"石药集团(01093)公布石药创新(300765.SZ)2024年第一季度业绩,营业收入约5.24亿元,同比减少27.08%;归属于上市公司股东的净利润约7906.13万元,同比减少38.86%;基本每股收益0.0676元。公告 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20240423/c657170941.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429972670","title":"图解新诺威一季报:第一季度单季净利润同比减38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429972670","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429972670?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:48","pubTimestamp":1713808088,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威2024年一季报显示,公司主营收入5.24亿元,同比下降27.08%;归母净利润7906.13万元,同比下降38.86%;扣非净利润7817.2万元,同比下降56.44%;负债率15.3%,投资收益-461.23万元,财务费用-1615.24万元,毛利率46.71%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300002233.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429210209","title":"新诺威最新公告:一季度净利润7906.13万元 同比下降38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429210209","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429210209?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:40","pubTimestamp":1713793238,"startTime":"0","endTime":"0","summary":"新诺威公布2024年一季度报告,报告期营业收入5.24亿元,同比下降27.08%;归属于上市公司股东的净利润7906.13万元,同比下降38.86%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200029778.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429210559","title":"石药集团(01093):石药创新(300765.SZ)一季度归母净利约7906.13万元 同比减少38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429210559","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429210559?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:35","pubTimestamp":1713792953,"startTime":"0","endTime":"0","summary":"石药集团(01093)公布石药创新(300765.SZ)2024年第一季度业绩,营...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107066.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429292629","title":"新诺威(300765.SZ)发布一季度业绩,净利润7906.13万元,下降38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429292629","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429292629?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:14","pubTimestamp":1713791680,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新诺威(300765.SZ)发布2024年第一季度报告,该公司营业收入为5.24亿元,同比减少27.08%。归属于上市公司股东的净利润为7906.13万元,同比减少38.86%。归属于上市公司股东的扣除非经常性损益的净利润为7817.2万元,同比减少56.44%。基本每股收益为0.0676元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107019.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419674353","title":"新诺威(300765.SZ)发布2023年度业绩,净利润7.56亿元,增长4.03%,拟10股转2股派3.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419674353","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2419674353?lang=zh_cn&edition=full","pubTime":"2024-03-14 18:56","pubTimestamp":1710413760,"startTime":"0","endTime":"0","summary":"新诺威发布2023年年度报告,该公司营业收入为25.02亿元,同比减少4.75%。归属于上市公司股东的净利润为7.56亿元,同比增长4.03%。基本每股收益为0.6533元。公告显示,公司的主营业务为大健康领域功能食品的研发、生产与销售。此外,拟向全体股东每10股派发现金红利3.2元(含税),以资本公积金向全体股东每10股转增2股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-14/doc-inanhvcq7709064.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-14/doc-inanhvcq7709064.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2414860019","title":"新诺威上市五年业绩连续双增 股价大涨194%两次调高回购价","url":"https://stock-news.laohu8.com/highlight/detail?id=2414860019","media":"长江商报","top":-1,"share":"https://www.laohu8.com/m/news/2414860019?lang=zh_cn&edition=full","pubTime":"2024-02-27 08:09","pubTimestamp":1708992540,"startTime":"0","endTime":"0","summary":"2023年8月24日,新诺威股价创下年内低点,9月21日公司发布首次回购方案,此后股价进入上涨通道。数据显示,新诺威是中国保健食品第一梯队企业,2019年3月上市,上市五年公司的营业收入和归母净利润均实现连续增长。进入2024年,新诺威股价大幅波动,目前再度涨至30元/股上方,超过回购价上限。截至目前,石药集团持有新诺威73.6%的股份。业绩方面,上市之后,新诺威的营业收入和归母净利润近五年连续实现双增。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-02-27/doc-inakmrzp1156678.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-02-27/doc-inakmrzp1156678.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2414906523","title":"新诺威:调整回购公司股份价格上限至38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2414906523","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2414906523?lang=zh_cn&edition=full","pubTime":"2024-02-25 18:14","pubTimestamp":1708856040,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,新诺威(300765)2月25日晚间公告,公司拟将回购价格上限由不超过26.11元/股(含)调整为不超过38元/股(含)。此次回购公司股份方案的其他内容未发生变化。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-02-25/doc-inakfyzf2974605.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-02-25/doc-inakfyzf2974605.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402108854","title":"新诺威:拟收购石药集团百克(山东)生物制药股份有限公司100%股权 1月11日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2402108854","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2402108854?lang=zh_cn&edition=full","pubTime":"2024-01-10 20:10","pubTimestamp":1704888600,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,新诺威(300765)1月10日晚间公告,公司正在筹划发行股份及支付现金购买石药集团百克(山东)生物制药股份有限公司(简称“百克生物”)100%的股权并募集配套资金,公司股票自2024年1月11日开市起停牌,预计在不超过10个交易日的时间内披露本次交易方案。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-01-10/doc-inacaaau4023337.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-01-10/doc-inacaaau4023337.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2400384452","title":"新诺威:公司已构建独立自主mRNA技术平台 采用自主研发模式进行产品研发工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2400384452","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2400384452?lang=zh_cn&edition=full","pubTime":"2024-01-04 10:56","pubTimestamp":1704336990,"startTime":"0","endTime":"0","summary":"新诺威(300765)在互动平台上表示,公司已构建独立自主的mRNA技术平台,采用自主研发模式进行产品研发工作。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65961fb353243c07837544f1","is_publish_highlight":false,"gpt_icon":0},{"id":"2395089476","title":"【年终盘点】2023年A股十大牛熊股出炉!","url":"https://stock-news.laohu8.com/highlight/detail?id=2395089476","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2395089476?lang=zh_cn&edition=full","pubTime":"2023-12-29 19:15","pubTimestamp":1703848540,"startTime":"0","endTime":"0","summary":"时光荏苒,转眼间,2023年交易行情已经结束。今","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202312_1/3ecfd01f-df91-4fa1-a61e-01f1342d3982.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202312_1/3ecfd01f-df91-4fa1-a61e-01f1342d3982.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/658eaa5cbde0b375aabeb002","is_publish_highlight":false,"gpt_icon":0},{"id":"2393016172","title":"新诺威(300765.SZ)控股股东完成增持274.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2393016172","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2393016172?lang=zh_cn&edition=full","pubTime":"2023-12-21 18:25","pubTimestamp":1703154300,"startTime":"0","endTime":"0","summary":"新诺威(300765.SZ)公告,公司控股股东石药集团恩必普药业有限公司(“恩必普药业”)通过深圳证券交易所交易系统以集中竞价方式累计增持公司股份274.26万股,占公司总股本的0.23%(已剔除最新披露的公司回购专用账户中的股份数量计算),增持金额为9998.88万元(不含手续费),本次增持计划已实施完成。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-21/doc-imzyupny4497327.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-21/doc-imzyupny4497327.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2389012815","title":"新诺威尾盘20CM跌停,成交超22亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2389012815","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2389012815?lang=zh_cn&edition=full","pubTime":"2023-12-07 14:50","pubTimestamp":1701931800,"startTime":"0","endTime":"0","summary":"新诺威尾盘20CM跌停,成交超22亿元。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-12-07/doc-imzxepnw1556675.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-12-07/doc-imzxepnw1556675.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2381127246","title":"新诺威涨8.17%,德邦证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2381127246","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2381127246?lang=zh_cn&edition=full","pubTime":"2023-11-06 17:04","pubTimestamp":1699261440,"startTime":"0","endTime":"0","summary":"今日涨8.17%,收盘报31.51元。2023年10月26日,德邦证券研究员陈铁林,刘闯发布了对新诺威的《Q3短期承压,加码创新药业务打开成长空间》,该研报对新诺威给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为德邦证券的王绍玲、陈铁林。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2023-11-06/doc-imztspfr0665619.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2023-11-06/doc-imztspfr0665619.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","stockEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":-0.0912},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.5236},{"period":"1year","weight":1.8894},{"period":"ytd","weight":-0.0202}],"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","perCapita":"65469股","boardName":"食品制造业","registeredCapital":"140459万元","compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.0987},{"period":"6month","weight":0.0237},{"period":"1year","weight":-0.0777},{"period":"ytd","weight":0.0234}],"survey":" 石药创新制药股份有限公司的主营业务是大健康领域功能食品的研发、生产与销售。公司的主要产品为功能性原料及保健食品类产品。公司“果维康”商标为中国驰名商标,“果维康”牌维生素C含片先后获得中国公众营养和发展中心“营养健康倡导产品”、“中华预防医学会健康金桥重点工程项目”、等多项荣誉。公司二甲紫脲酸高选择性催化还原新工艺,可可碱生产新工艺经河北省科学技术厅的认定,达到国内领先水平,并获得了河北省科学技术成果奖。公司专利“一种咖啡因中间体N,N-1,3-二甲基-4,5-二氨基脲嗪的制备方法”荣获2018年河北省专利奖优秀奖。","serverTime":1713870209830,"listedPrice":24.47,"stockholders":"19048人(较上一季度减少2.04%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新诺威,300765,新诺威股票,新诺威股票老虎,新诺威股票老虎国际,新诺威行情,新诺威股票行情,新诺威股价,新诺威股市,新诺威股票价格,新诺威股票交易,新诺威股票购买,新诺威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}